18.12.2025 — Breakthrough in Miniaturization (Newswire)
Liom achieves miniaturization breakthrough and brings total Series A funding to CHF 38m
Liom announced a breakthrough in miniaturising its proprietary Raman spectroscopy platform for non-invasive biomarker monitoring, along with a CHF 13m extension to its Series A financing round.
13.04.2025 — Liom “Die Handleser” (Bilanz)
Liom Health will schaffen, woran Apple und Samsung bislang scheitern: Biomarker wie Glukose am Handgelenk messen
Interview with our founder and CEO Leo Grünstein on Liom’s vision, achievements, and next steps.
30.01.2025 — Calibration-Free Non-Invasive Glucose Monitoring Published in JDST (Newswire)
Liom publishes groundbreaking calibration-free non-invasive glucose monitoring results
Liom releases results from one of its external clinical studies in the Journal of Diabetes Science and Technology (JDST), marking a major milestone for its non-invasive glucose monitoring technology.
04.12.2024 — Liom Cracks “Holy Grail” of Non-Invasive Glucose Monitoring (Newswire)
Liom secures >USD 25m in funding, kickstarting its Series A
Liom announces significant technological breakthroughs and the successful launch of its Series A round.
31.07.2024 — New Brand: Spiden Becomes Liom (LinkedIn)
Spiden is becoming Liom
Liom announces its rebranding, advancing its mission to achieve non-invasive glucose monitoring integrated into the ultimate health wearable.
05.01.2024 — Breakthrough in Non-Invasive Glucose Monitoring (Newswire)
Liom announces new breakthrough and secures USD 15m in additional funding
Liom reveals advancements in non-invasive glucose monitoring, adds key executive hires, and strengthens its financial foundation.
04.09.2023 — Disrupting the Smart Wearables Industry (Impulse Podcast)
Interview with CEO Leo Grünstein
Leo Grünstein discusses Liom’s path to creating the most advanced wearable capable of continuously and non-invasively measuring multiple biomarkers.
18.08.2023 — Liom will Apple bei Blutzucker-Technik überholen (Handelsblatt)
Liom will Apple bei Blutzucker-Technik überholen
Das Schweizer Start-up entwickelt einen Handgelenk-Tracker, der den Blutzuckerspiegel ohne Nadelstich misst und damit die Behandlung für Diabetiker vereinfachen könnte.
29.04.2021 — Liom Raises CHF 18m (Businesswire)
Liom raises CHF 18 million
Swiss-based longevity-focused startup Liom raises $18 million to expand its Light+AI-based real-time blood diagnostics platform.
15.06.2023 — ISO 13485:2016 Certification
ISO 13485:2016 certification
Liom has been assessed and certified as meeting the requirements of ISO 13485:2016 for the design and development of non-invasive medical devices for measuring biomarkers and drugs in bodily fluids and tissues.
11.06.2022 — Move into New 1800m² Office & Visitor Day
Move into new 1800m² office & visitor day
To accommodate our growing team and needs for high-performance infrastructure, Liom has relocated to a new 1800m² office in Pfäffikon SZ. Marking this significant milestone, we invited partners, investors, and other stakeholders to our new facilities.